Advertisement

PharmacoEconomics & Outcomes News

, Volume 818, Issue 1, pp 21–21 | Cite as

OnabotA best treatment option for overactive bladder

Clinical study
  • 8 Downloads

Reference

  1. Murray B, et al. Cost-effectiveness of overactive bladder treatments: from the US payer perspective. Journal of Comparative Effectiveness Research : 4 Dec 2018. Available from: URL: https://doi.org/10.2217/cer-2018-0079

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations